Novel target to inhibit angiogenesis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20050119198A1
SERIAL NO

10502244

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the field of angiogenesis. In particular the invention relates to the use of molecules binding to prominin-1 that can be used for the manufacture of a medicament to prevent pathological angiogenesis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE VZWRIJVISSCHESTRAAT 120 ZWIJNAARDE B-9052 BELGIUM
D COLLEN RESEARCH FOUNDATION VZWK U LEUVEN HERESTRAAT 49

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Carmeliet, Peter Blanden, BE 50 274
Moons, Lieve Herselt, BE 1 14

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation